Health
Researchers uncover potentially promising therapeutic combination for renal cell carcinoma – Medical Xpress
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney…
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide. Currently, the 5-year survival rate for patients with metastatic RCC is only about 12 percent. Current treatments include inhibitors of the VEGF and PD-1 pathways. However, resistance to therapy occurs in most patients and new combination treatments are still needed to enhance the efficacy of these current approaches.
Now,…
-
General24 hours agoTens of thousands protest in nationwide action against war in Gaza
-
Noosa News21 hours agoChild sex offenders to be known in Queensland public registry
-
General21 hours agoThousands flood cities demanding action on Palestine
-
General23 hours agoAuthorities say charged man used false name to escape from Perth court